Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A MacGREGOR

Showing results (191-200 of 973) with videos related to

Pageof 98
Sort By:
British Journal of Clinical Pharmacology|June 1, 1976
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal manG A MacGregor, P M Dawes
Progress in Cardiovascular Diseases|March 16, 2010
Reducing population salt intake worldwide: from evidence to implementationFeng J He, Graham A MacGregor
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 28, 2012
Nanopsychiatry--the potential role of nanotechnologies in the future of psychiatry: a systematic reviewG Fond, A Macgregor, S Miot
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Salt - The DASH-Sodium trialF J He, G A MacGregor
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Blood pressure and stroke; the PROGRESS trialF J He, G A MacGregor
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockersP A Swift, G A MacGregor
Lancet (London, England)|May 30, 1998
Sodium intake and mortalityH de Wardener, G A MacGregor
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
The frequent need for three or more drugs to treat essential hypertension. What evidence for optimal combinations?Pauline A Swift, Graham A MacGregor
Journal of Human Hypertension|June 25, 2003
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per yearF J He, G A MacGregor
Regulatory Toxicology and Pharmacology : RTP|May 6, 2014
Vanadium pentoxide: risk assessment implications of a treatment- but not dose-related tumorigenic response in B6C3F1 miceThomas B Starr, Judith A MacGregor
Pageof 98

Showing results (191-200 of 973) with videos related to

Sort By:
Pageof 98
British Journal of Clinical Pharmacology|June 1, 1976
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal manG A MacGregor, P M Dawes
Progress in Cardiovascular Diseases|March 16, 2010
Reducing population salt intake worldwide: from evidence to implementationFeng J He, Graham A MacGregor
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 28, 2012
Nanopsychiatry--the potential role of nanotechnologies in the future of psychiatry: a systematic reviewG Fond, A Macgregor, S Miot
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Salt - The DASH-Sodium trialF J He, G A MacGregor
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Blood pressure and stroke; the PROGRESS trialF J He, G A MacGregor
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockersP A Swift, G A MacGregor
Lancet (London, England)|May 30, 1998
Sodium intake and mortalityH de Wardener, G A MacGregor
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
The frequent need for three or more drugs to treat essential hypertension. What evidence for optimal combinations?Pauline A Swift, Graham A MacGregor
Journal of Human Hypertension|June 25, 2003
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per yearF J He, G A MacGregor
Regulatory Toxicology and Pharmacology : RTP|May 6, 2014
Vanadium pentoxide: risk assessment implications of a treatment- but not dose-related tumorigenic response in B6C3F1 miceThomas B Starr, Judith A MacGregor
Pageof 98